Marion Villars-Gauthier
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 81 publications
BARD1 and breast cancer genetic predisposition: case-control study and HRD signature analysis.
Journal: Breast cancer (Tokyo, Japan)
Published: December 05, 2025
Uveal Melanoma and the Lynch Syndrome Tumor Spectrum.
Journal: JAMA ophthalmology
Published: June 18, 2025
Retinocytoma: Clinical and Genetic Characteristics in 16 Pediatric and Adult Cases.
Journal: Ocular oncology and pathology
Published: May 29, 2025
Methylation-sensitive high-resolution melting technology is a simple and sensitive method to detect germline epimutation of the MLH1 gene promoter.
Journal: Clinical epigenetics
Published: March 24, 2025
Screening Mammography and Breast Cancer: Variation in Risk with Rare Deleterious or Predicted Deleterious Variants in DNA Repair Genes.
Journal: Cancers
Published: February 03, 2025
A functional assay to classify RB1 variants of uncertain significance.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: January 17, 2025
Deciphering dual clinical entities associated with TP53 pathogenic variants: Insights from 53,085 HBOC panel analyses in French laboratories.
Journal: International journal of cancer
Published: September 26, 2024
SMARCB1-deficient malignant melanocytic uveal tumours: a new neural crest-derived tumour entity with SMARCB1-related germline predisposition.
Journal: The Journal of pathology
Published: August 15, 2024
Postzygotic mosaicism of SMARCB1 variants in patients with rhabdoid tumors: A not-so-rare condition exposing to successive tumors.
Journal: Neuro-oncology
Published: August 02, 2024
Medulloblastomas with ELP1 pathogenic variants: A weakly penetrant syndrome with a restricted spectrum in a limited age window.
Journal: Neuro-oncology advances
Published: July 04, 2024
Bone sarcomas and cancer predisposition syndromes.
Journal: Bulletin du cancer
Published: June 30, 2024
PHOX2B -associated Congenital Central Hypoventilation Syndrome Revealed Upon Treatment With Dinutuximab-beta.
Journal: Journal of pediatric hematology/oncology
Published: March 12, 2024
Last Updated: 09/26/2026